(note: SPACInsider will only publish pricing once a team officially puts out their own press release. XPAC did not publish their press release until 6:00PM ET on 7/30/21)
XPAC Acquisition Corp. announced the pricing of its $200 million IPO and its shares are expected to begin trading on the Nasdaq under the symbol “XPAXU” Friday, July 30.
The new SPAC aims to combine with a target that is a leading player and high-quality asset within the Brazilian economy, and has a defensible market position. XPAC is led by Chairman and CEO Chu Kong, CIO Guilherme Teixeira, and CFO Fabio Kann.
Total SPAC deal count for 2021 year-to-date is now 388. This offering is expected to close on Monday, August 2.
Citigroup acted as sole book-running manager. XP Investimentos Corretora de Câmbio, Títulos e Valores Mobiliários S.A. acted as financial advisor. Skadden, Arps, Slate, Meagher & Flom LLP is serving as Issuer’s Counsel with Shearman & Sterling LLP serving as Underwriter’s Counsel. Marcum LLP serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...
At the SPAC of Dawn Ever since Digital World announced its combination with Trump Media (NASDAQ:DJT) back in October 2021, it was clear that SPACworld and the Trump show were set to be intertwined for quite some time. And, although not every headline has a bearing on the wider SPAC world, Trump Media’s post-close rise...
AltC (NYSE:ALCC) has reportedly been taking the pitch deck for its combination with nuclear fission firm Oklo on the road in recent weeks, which has generated the rare result of a SPAC trading significantly above its trust value still well before completing its deal. The SPAC has an estimated $10.59 per share in its trust...